On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does not

Author： Citrome Leslie Nasrallah Henry A

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.11, 2012-08, pp. : 1599-1613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolerability Profile of Atypical Antipsychotics in Children and Adolescents

By Stigler K.A.

Pediatric Drugs, Vol. 3, Iss. 12, 2001-01 ,pp. : 927-942

Adis International

Access to resources Recommend Favorite

Tolerability of Atypical Antipsychotics

By Stanniland C. Taylor D.

Drug Safety, Vol. 22, Iss. 3, 2000-03 ,pp. : 195-214

Adis International

Access to resources Recommend Favorite

Comparative Effectiveness of Atypical Antipsychotics in Schizophrenia: What have Real-World Trials Taught Us?

By Attard Azizah Taylor David M.

CNS Drugs, Vol. 26, Iss. 6, 2012-06 ,pp. : 491-508

Adis International

Access to resources Recommend Favorite

What's atypical about atypical antipsychotic drugs?

By Meltzer H.Y.

Current Opinion in Pharmacology, Vol. 4, Iss. 1, 2004-02 ,pp. : 53-57

Elsevier

Access to resources Recommend Favorite

The safety and tolerability of atypical antipsychotics in bipolar disorder

By Seemüller Florian Forsthoff Anna Dittmann Sandra Born Christoph Bernhard Britta Severus W Emanuel Grunze Heinz

Expert Opinion on Drug Safety, Vol. 4, Iss. 5, 2005-09 ,pp. : 849-868

Informa Healthcare

Access to resources Recommend Favorite